-transparent.png){kind=logo}
Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazine. 1994
Department of Psychiatry, Mount Sinai School of Medicine/Bronx Veterans Administration Hospital, New York, NY.
The effects of clozapine treatment on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazine (mCPP) were examined. mCPP and placebo were administered after a 2-week drug-free period and again after 5 weeks of clozapine treatment in nine schizophrenic inpatients. Adrenocorticotropic hormone (ACTH), prolactin, and mCPP levels were measured. Clozapine treatment completely blocked mCPP-induced ACTH and prolactin release suggesting that clozapine blocks serotonin receptors that mediate these hormone responses.
Related Publications
R S Kahn, and
M Davidson, and
L J Siever, and
S Sevy, and
K L Davis
December 1985,
The Journal of clinical endocrinology and metabolism,
R S Kahn, and
M Davidson, and
L J Siever, and
S Sevy, and
K L Davis
April 1997,
The Journal of clinical endocrinology and metabolism,
R S Kahn, and
M Davidson, and
L J Siever, and
S Sevy, and
K L Davis
June 1988,
Clinical pharmacology and therapeutics,
R S Kahn, and
M Davidson, and
L J Siever, and
S Sevy, and
K L Davis
July 2003,
Neuroendocrinology,
R S Kahn, and
M Davidson, and
L J Siever, and
S Sevy, and
K L Davis
June 1988,
European journal of pharmacology,
R S Kahn, and
M Davidson, and
L J Siever, and
S Sevy, and
K L Davis
August 1993,
Archives of general psychiatry,
R S Kahn, and
M Davidson, and
L J Siever, and
S Sevy, and
K L Davis
November 1992,
Archives of general psychiatry,
R S Kahn, and
M Davidson, and
L J Siever, and
S Sevy, and
K L Davis
November 1995,
Neuroreport,
R S Kahn, and
M Davidson, and
L J Siever, and
S Sevy, and
K L Davis
November 1992,
The Journal of pharmacology and experimental therapeutics,
R S Kahn, and
M Davidson, and
L J Siever, and
S Sevy, and
K L Davis
September 1995,
Psychiatry research,
